Most patients begin losing weight within the first four weeks of treatment, with the rate of loss varying during the dose escalation phase
At neutral to alkaline pH (above 7), deamidation proceeds through a cyclic imide intermediate that produces a mixture of normal and isomerized products
Wegovy works by binding to the same receptors as GLP-1 which in turn has the same effect of making you feel fuller while reducing your appetite to help manage food cravings
About one in eight (12%) American adults have taken a GLP-1 agonist at some point, while 6% were actively taking them as of spring 2024 (KFF, 2024)
This means weight loss results will also vary from person to person
At 20 units on your 5mg/ml syringe, you are now drawing a volume that is clearly visible in the barrel, which makes measurement somewhat easier than the tiny volumes of the earlier phases